(Q37956520)

25 August 2017

title

Are we ready to start studies of Th17 cell manipulation as a therapy for cancer? (English)

1 reference

25 August 2017

2

Nicola E Annels

1 reference

25 August 2017

3

Hardev S Pandha

1 reference

25 August 2017

Gary W Middleton

1

1 reference

25 August 2017

publication date

16 November 2011

1 reference

Cancer Immunology, Immunotherapy

25 August 2017

published in

1 reference

25 August 2017

volume

61

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

1-7

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-011-1151-y

25 August 2017

exact match

0 references

cites work

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

IL-17A controls IL-17F production and maintains blood neutrophil counts in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Th17 cells: positive or negative role in tumor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behavior of Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Human tumor-infiltrating Th17 cells have the capacity to differentiate into IFN-γ+ and FOXP3+ T cells with potent suppressive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

IL-21 and TGF-beta are required for differentiation of human T(H)17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Development, cytokine profile and function of human interleukin 17-producing helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

IFN-γ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Tumor-specific Th17-polarized cells eradicate large established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Late developmental plasticity in the T helper 17 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Eotaxin-2 generation is differentially regulated by lipopolysaccharide and IL-4 in monocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

Pretreatment frequency of circulating IL-17+CD4+T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1151-Y

10.1007/S00262-011-1151-Y

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference